Sfoglia per Autore
A study to investigate the influence of cardiac motion on the robustness of pencil beam scanning proton plans in oesophageal cancer
2020-01-01 Thomas M.; Defraene G.; Levis M.; Sterpin E.; Lambrecht M.; Ricardi U.; Haustermans K.
68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy
2020-01-01 Deandreis D.; Guarneri A.; Ceci F.; Lillaz B.; Bartoncini S.; Oderda M.; Nicolotti D.G.; Pilati E.; Passera R.; Zitella A.; Bello M.; Parise R.; Carlevato R.; Ricardi U.; Gontero P.
Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial
2020-01-01 Francesca Arcadipane, Patrick Silvetti, Francesco Olivero, Alessio Gastino, Viola De Luca, Massimiliano Mistrangelo, Paola Cassoni, Patrizia Racca, Elena Gallio, Adriana Lesca, Christian Fiandra, Umberto Ricardi, Pierfrancesco Franco
Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy
2020-01-01 Alterio D.; D'Ippolito E.; Vischioni B.; Fossati P.; Gandini S.; Bonora M.; Ronchi S.; Vitolo V.; Mastella E.; Magro G.; Franco P.; Ricardi U.; Krengli M.; Ivaldi G.; Ferrari A.; Fanetti G.; Comi S.; Tagliabue M.; Verri E.; Ricotti R.; Ciardo D.; Jereczek-Fossa B.A.; Valvo F.; Orecchia R.
Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: A multi-institutional study of adult patients by ILROG
2020-01-01 Binkley M.S.; Shahzad Rauf M.; Milgrom S.A.; Pinnix C.C.; Tsang R.; Dickinson M.; Ng A.K.; Roberts K.B.; Gao S.; Balogh A.; Ricardi U.; Levis M.; Casulo C.; Stolten M.; Specht L.; Plastaras J.P.; Wright C.; Kelsey C.R.; Brady J.L.; George Mikhaeel N.; Hoppe B.S.; Terezakis S.A.; Picardi M.; Pepa R.D.; Kirova Y.; Akhtar S.; Maghfoor I.; Koenig J.L.; Jackson C.; Song E.; Sehgal S.; Advani R.H.; Natkunam Y.; Constine L.S.; Eich H.T.; Wirth A.; Hoppe R.T.
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2020-01-01 Zucca E.; Arcaini L.; Buske C.; Johnson P.W.; Ponzoni M.; Raderer M.; Ricardi U.; Salar A.; Stamatopoulos K.; Thieblemont C.; Wotherspoon A.; Ladetto M.
Automatic genetic planning for volumetric modulated arc therapy: A large multi-centre validation for prostate cancer
2020-01-01 Fiandra C.; Rossi L.; Alparone A.; Zara S.; Vecchi C.; Sardo A.; Bartoncini S.; Loi G.; Pisani C.; Gino E.; Ruo Redda M.G.; Marco Deotto G.; Tini P.; Comi S.; Zerini D.; Ametrano G.; Borzillo V.; Strigari L.; Strolin S.; Savini A.; Romeo A.; Reccanello S.; Rumeileh I.A.; Ciscognetti N.; Guerrisi F.; Balestra G.; Ricardi U.; Heijmen B.
Effect of COVID-19 pandemic on practice in European radiation oncology centers
2020-01-01 Slotman B.J.; Lievens Y.; Poortmans P.; Cremades V.; Eichler T.; Wakefield D.V.; Ricardi U.
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
2020-01-01 Jereczek-Fossa B.A.; Pepa M.; Marvaso G.; Bruni A.; Buglione di Monale e Bastia M.; Catalano G.; Filippi A.R.; Franco P.; Gambacorta M.A.; Genovesi D.; Iati G.; Magli A.; Marafioti L.; Meattini I.; Merlotti A.; Mignogna M.; Musio D.; Pacelli R.; Pergolizzi S.; Tombolini V.; Trovo M.; Ricardi U.; Magrini S.M.; Corvo R.; Donato V.
Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
2020-01-01 Poon I.; Erler D.; Dagan R.; Redmond K.J.; Foote M.; Badellino S.; Biswas T.; Louie A.V.; Lee Y.; Atenafu E.G.; Ricardi U.; Sahgal A.
Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease
2020-01-01 Qi S.; Milgrom S.; Dabaja B.; Tsang R.; Levis M.; Ricardi U.; Lopez-Alonso R.; Dann E.J.; Ng A.; Yahalom J.
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
2020-01-01 Guckenberger M.; Belka C.; Bezjak A.; Bradley J.; Daly M.E.; DeRuysscher D.; Dziadziuszko R.; Faivre-Finn C.; Flentje M.; Gore E.; Higgins K.A.; Iyengar P.; Kavanagh B.D.; Kumar S.; Le Pechoux C.; Lievens Y.; Lindberg K.; McDonald F.; Ramella S.; Rengan R.; Ricardi U.; Rimner A.; Rodrigues G.B.; Schild S.E.; Senan S.; Simone II C.B.; Slotman B.J.; Stuschke M.; Videtic G.; Widder J.; Yom S.S.; Palma D.
National societies' needs as assessed by the ESTRO National Societies Committee survey: A European perspective
2020-01-01 Garibaldi C.; Jornet N.; Tan L.T.; Boejen A.; Franco P.; Bussink J.; Troost E.G.C.; Bak B.; Bibault J.-E.; Dzhugashvili M.; Van den Berghe L.; Fizaine L.; Leci A.; Ricardi U.; Jereczek-Fossa B.A.
Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459)
2020-01-01 Fastner G.; Reitsamer R.; Urbanski B.; Kopp P.; Murawa D.; Adamczyk B.; Karzcewska A.; Milecki P.; Hager E.; Reiland J.; Ciabattoni A.; Matuschek C.; Budach W.; Nowell K.; Schumacher C.; Ricke A.; Fusco V.; Vidali C.; Alessandro M.; Ivaldi G.B.; Ziegler I.; Fussl C.; Zehentmayr F.; Grambozov B.; Sir A.; Hitzl W.; Ricardi U.; Sedlmayer F.
Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience
2020-01-01 Krengli M.; Ferrara E.; Mastroleo F.; Brambilla M.; Ricardi U.
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
2020-01-01 Guckenberger M.; Lievens Y.; Bouma A.B.; Collette L.; Dekker A.; deSouza N.M.; Dingemans A.-M.C.; Fournier B.; Hurkmans C.; Lecouvet F.E.; Meattini I.; Romero A.M.; Ricardi U.; Russell N.S.; Schanne D.H.; Scorsetti M.; Tombal B.; Verellen D.; Verfaillie C.; Ost P.
The importance of IL-6 blockade beyond the COVID-19 pandemic: Consideration for cancer care
2020-01-01 Iorio G.C.; Ricardi U.; Franco P.
Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic
2020-01-01 Iorio G.C.; Ricardi U.; Dal Pra A.
Ocular complications after radiation therapy: An observational study
2020-01-01 Nuzzi R.; Trossarello M.; Bartoncini S.; Marolo P.; Franco P.; Mantovani C.; Ricardi U.
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer
2020-01-01 Le Pechoux C.; Faivre-Finn C.; Ramella S.; McDonald F.; Manapov F.; Putora P.M.; Slotman B.; De Ruysscher D.; Ricardi U.; Geets X.; Belderbos J.; Pottgen C.; Dziadiuszko R.; Peeters S.; Lievens Y.; Hurkmans C.; Van Houtte P.; Nestle U.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A study to investigate the influence of cardiac motion on the robustness of pencil beam scanning proton plans in oesophageal cancer | 2020 | Thomas M.; Defraene G.; Levis M.; Sterpin E.; Lambrecht M.; Ricardi U.; Haustermans K. | |
68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy | 2020 | Deandreis D.; Guarneri A.; Ceci F.; Lillaz B.; Bartoncini S.; Oderda M.; Nicolotti D.G.; Pilati E.; Passera R.; Zitella A.; Bello M.; Parise R.; Carlevato R.; Ricardi U.; Gontero P. | |
Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial | 2020 | Francesca Arcadipane, Patrick Silvetti, Francesco Olivero, Alessio Gastino, Viola De Luca, Massimiliano Mistrangelo, Paola Cassoni, Patrizia Racca, Elena Gallio, Adriana Lesca, Christian Fiandra, Umberto Ricardi, Pierfrancesco Franco | |
Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy | 2020 | Alterio D.; D'Ippolito E.; Vischioni B.; Fossati P.; Gandini S.; Bonora M.; Ronchi S.; Vitolo V.; Mastella E.; Magro G.; Franco P.; Ricardi U.; Krengli M.; Ivaldi G.; Ferrari A.; Fanetti G.; Comi S.; Tagliabue M.; Verri E.; Ricotti R.; Ciardo D.; Jereczek-Fossa B.A.; Valvo F.; Orecchia R. | |
Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: A multi-institutional study of adult patients by ILROG | 2020 | Binkley M.S.; Shahzad Rauf M.; Milgrom S.A.; Pinnix C.C.; Tsang R.; Dickinson M.; Ng A.K.; Roberts K.B.; Gao S.; Balogh A.; Ricardi U.; Levis M.; Casulo C.; Stolten M.; Specht L.; Plastaras J.P.; Wright C.; Kelsey C.R.; Brady J.L.; George Mikhaeel N.; Hoppe B.S.; Terezakis S.A.; Picardi M.; Pepa R.D.; Kirova Y.; Akhtar S.; Maghfoor I.; Koenig J.L.; Jackson C.; Song E.; Sehgal S.; Advani R.H.; Natkunam Y.; Constine L.S.; Eich H.T.; Wirth A.; Hoppe R.T. | |
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | 2020 | Zucca E.; Arcaini L.; Buske C.; Johnson P.W.; Ponzoni M.; Raderer M.; Ricardi U.; Salar A.; Stamatopoulos K.; Thieblemont C.; Wotherspoon A.; Ladetto M. | |
Automatic genetic planning for volumetric modulated arc therapy: A large multi-centre validation for prostate cancer | 2020 | Fiandra C.; Rossi L.; Alparone A.; Zara S.; Vecchi C.; Sardo A.; Bartoncini S.; Loi G.; Pisani C.; Gino E.; Ruo Redda M.G.; Marco Deotto G.; Tini P.; Comi S.; Zerini D.; Ametrano G.; Borzillo V.; Strigari L.; Strolin S.; Savini A.; Romeo A.; Reccanello S.; Rumeileh I.A.; Ciscognetti N.; Guerrisi F.; Balestra G.; Ricardi U.; Heijmen B. | |
Effect of COVID-19 pandemic on practice in European radiation oncology centers | 2020 | Slotman B.J.; Lievens Y.; Poortmans P.; Cremades V.; Eichler T.; Wakefield D.V.; Ricardi U. | |
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) | 2020 | Jereczek-Fossa B.A.; Pepa M.; Marvaso G.; Bruni A.; Buglione di Monale e Bastia M.; Catalano G.; Filippi A.R.; Franco P.; Gambacorta M.A.; Genovesi D.; Iati G.; Magli A.; Marafioti L.; Meattini I.; Merlotti A.; Mignogna M.; Musio D.; Pacelli R.; Pergolizzi S.; Tombolini V.; Trovo M.; Ricardi U.; Magrini S.M.; Corvo R.; Donato V. | |
Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis | 2020 | Poon I.; Erler D.; Dagan R.; Redmond K.J.; Foote M.; Badellino S.; Biswas T.; Louie A.V.; Lee Y.; Atenafu E.G.; Ricardi U.; Sahgal A. | |
Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease | 2020 | Qi S.; Milgrom S.; Dabaja B.; Tsang R.; Levis M.; Ricardi U.; Lopez-Alonso R.; Dann E.J.; Ng A.; Yahalom J. | |
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement | 2020 | Guckenberger M.; Belka C.; Bezjak A.; Bradley J.; Daly M.E.; DeRuysscher D.; Dziadziuszko R.; Faivre-Finn C.; Flentje M.; Gore E.; Higgins K.A.; Iyengar P.; Kavanagh B.D.; Kumar S.; Le Pechoux C.; Lievens Y.; Lindberg K.; McDonald F.; Ramella S.; Rengan R.; Ricardi U.; Rimner A.; Rodrigues G.B.; Schild S.E.; Senan S.; Simone II C.B.; Slotman B.J.; Stuschke M.; Videtic G.; Widder J.; Yom S.S.; Palma D. | |
National societies' needs as assessed by the ESTRO National Societies Committee survey: A European perspective | 2020 | Garibaldi C.; Jornet N.; Tan L.T.; Boejen A.; Franco P.; Bussink J.; Troost E.G.C.; Bak B.; Bibault J.-E.; Dzhugashvili M.; Van den Berghe L.; Fizaine L.; Leci A.; Ricardi U.; Jereczek-Fossa B.A. | |
Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459) | 2020 | Fastner G.; Reitsamer R.; Urbanski B.; Kopp P.; Murawa D.; Adamczyk B.; Karzcewska A.; Milecki P.; Hager E.; Reiland J.; Ciabattoni A.; Matuschek C.; Budach W.; Nowell K.; Schumacher C.; Ricke A.; Fusco V.; Vidali C.; Alessandro M.; Ivaldi G.B.; Ziegler I.; Fussl C.; Zehentmayr F.; Grambozov B.; Sir A.; Hitzl W.; Ricardi U.; Sedlmayer F. | |
Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience | 2020 | Krengli M.; Ferrara E.; Mastroleo F.; Brambilla M.; Ricardi U. | |
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation | 2020 | Guckenberger M.; Lievens Y.; Bouma A.B.; Collette L.; Dekker A.; deSouza N.M.; Dingemans A.-M.C.; Fournier B.; Hurkmans C.; Lecouvet F.E.; Meattini I.; Romero A.M.; Ricardi U.; Russell N.S.; Schanne D.H.; Scorsetti M.; Tombal B.; Verellen D.; Verfaillie C.; Ost P. | |
The importance of IL-6 blockade beyond the COVID-19 pandemic: Consideration for cancer care | 2020 | Iorio G.C.; Ricardi U.; Franco P. | |
Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic | 2020 | Iorio G.C.; Ricardi U.; Dal Pra A. | |
Ocular complications after radiation therapy: An observational study | 2020 | Nuzzi R.; Trossarello M.; Bartoncini S.; Marolo P.; Franco P.; Mantovani C.; Ricardi U. | |
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer | 2020 | Le Pechoux C.; Faivre-Finn C.; Ramella S.; McDonald F.; Manapov F.; Putora P.M.; Slotman B.; De Ruysscher D.; Ricardi U.; Geets X.; Belderbos J.; Pottgen C.; Dziadiuszko R.; Peeters S.; Lievens Y.; Hurkmans C.; Van Houtte P.; Nestle U. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile